This element represents the amount of recognized equity-based compensation during the period, that is, the amount recognized as expense in the income statement (or as asset if compensation is capitalized). Alternate captions include the words "stock-based compensation".

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 35

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415241&loc=d3e4534-113899

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 20

-Section 55

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=32706628&loc=d3e11149-113907

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 20

-Section 55

-Paragraph 13

-URI http://asc.fasb.org/extlink&oid=32706628&loc=d3e11178-113907

Consolidated Statements of Shareholders' Equity (USD $) In Thousands, except Share data, unless otherwise specified	Total	Common Stock	Additional Paid-in Capital	Other Comprehensive Income (Loss)	Retained Earnings
Balance at the beginning of the period at Dec. 31, 2012	$ 66,668	$ 9	$ 40,430	$ 0	$ 26,229
Common stock outstanding, beginning (in shares) at Dec. 31, 2012		9,163,462
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)		122,650
Exercise of stock options (in values)	489		489
Stock Repurchased (in shares)		(300,087)
Stock Repurchased (in dollars)	(2,416)				(2,416)
Issuance of common stock in connection with acquisition of Sabine	0
Tax benefit - stock option exercise	96		96
Compensation cost associated with ASC Topic 718	296		296
Employee Stock Purchase Plan (in shares)		55
Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax	23			23
Net income	5,179us-gaap_ProfitLoss				5,179
Balance at end of the period at Dec. 31, 2013	70,335	9	41,311	23	28,992
Common stock outstanding, ending (in shares) at Dec. 31, 2013	8,986,080us-gaap_CommonStockSharesOutstanding	8,986,080
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)	234,432	234,432
Exercise of stock options (in values)	1,337		1,337
Stock Repurchased (in shares)		(272,767)
Stock Repurchased (in dollars)	(2,598)				(2,598)
Dividends, Cash	(914)us-gaap_DividendsCash				(914)
Stock Issued During Period, Shares, Acquisitions		150,000
Issuance of common stock in connection with acquisition of Sabine	1,679		1,679
Tax benefit - stock option exercise	211		211
Compensation cost associated with ASC Topic 718	401		401
Employee Stock Purchase Plan (in shares)		82
Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax	14			14
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax	(45)			(45)
Net income	5,596us-gaap_ProfitLoss				5,596
Balance at end of the period at Dec. 31, 2014	$ 76,016	$ 9	$ 44,939	$ (8)	$ 31,076
Common stock outstanding, ending (in shares) at Dec. 31, 2014	9,097,827us-gaap_CommonStockSharesOutstanding	9,097,827